Article

A Role for Nucleocapsid-Specific Antibody Function in COVID-19 Convalescent Plasma Therapy

2022-03-08

Abstract excerpt

COVID-19 convalescent plasma (CCP), a passive polyclonal antibody therapeutic, has exhibited mixed results in the treatment of COVID-19. Given that the therapeutic effect of CCP may extend beyond the ability of SARS-CoV-2-specific antibody binding and neutralization to influence the evolution of the endogenous antibody response, we took a systematic and comprehensive approach to analyze SARS-CoV-2 functional antib...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e06eb5e2-c2a4-516e-8346-35d539e1d01b
DOI: 10.2139/ssrn.4052956

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Role for Nucleocapsid-Specific Antibody Function in COVID-19 Convalescent Plasma TherapyDOI 10.2139/ssrn.4052956Read

Functional Antibodies in COVID-19 Convalescent PlasmaSemantic proximity Read

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasmaSemantic proximity Read

Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read

Elucidating the Humoral Immune Response to SARS-CoV-2: Isolation and Characterization of Monoclonal Antibodies from Convalescent COVID-19 PatientsSemantic proximity Read

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationSemantic proximity Read

Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVIDSemantic proximity Read

Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2Semantic proximity Read

Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infectionSemantic proximity Read

Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid ProteinsSemantic proximity Read

Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation patternSemantic proximity Read

Preclinical Efficacy of IMM-BCP-01, a Highly Active Patient-Derived Anti-SARS-CoV-2 Antibody CocktailSemantic proximity Read

<i>de Novo</i> Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 VaccinationSemantic proximity Read